Search research articles
Contact Us
Filters
Showing results (131-140 of 219) with videos related to
Page
of 22
Sort By:
Chest
|
July 1, 1997
Short-term incarceration for the management of noncompliance with tuberculosis treatment
W J Burman, D L Cohn, C A Rietmeijer, et al.
Plos Medicine
|
August 22, 2008
Ensuring the involvement of children in the evaluation of new tuberculosis treatment regimens
William J Burman, Mark F Cotton, Diana M Gibb, et al.
AIDS Patient Care and Stds
|
August 2, 2014
Engagement-in-care during the first 5 years after HIV diagnosis: data from a cohort of newly HIV-diagnosed individuals in a large US city
Sarah E Rowan, William J Burman, Steven C Johnson, et al.
Neurobiology of Disease
|
May 22, 2025
Network models incorporating chloride dynamics predict optimal strategies for terminating status epilepticus
Christopher B Currin, Richard J Burman, Tommaso Fedele, et al.
Journal of Clinical Microbiology
|
April 1, 1997
The diagnostic yield of acid-fast-bacillus smear-positive sputum specimens
B L Stone, W J Burman, M V Hildred, et al.
The American Journal of Medicine
|
November 23, 2013
Avoidable antibiotic exposure for uncomplicated skin and soft tissue infections in the ambulatory care setting
Hermione J Hurley, Bryan C Knepper, Connie S Price, et al.
Nature Reviews. Neurology
|
May 10, 2022
Why won't it stop? The dynamics of benzodiazepine resistance in status epilepticus
Richard J Burman, Richard E Rosch, Jo M Wilmshurst, et al.
Nature Reviews. Neurology
|
May 18, 2022
Author Correction: Why won't it stop? The dynamics of benzodiazepine resistance in status epilepticus
Richard J Burman, Richard E Rosch, Jo M Wilmshurst, et al.
AIDS Care
|
October 6, 2025
The "ART review": formalizing a process to document complex HIV treatment histories and to support treatment optimization
Kellie L Hawkins, Leila S Hojat, Carrie Hicks, et al.
HIV Medicine
|
February 26, 2015
Quality of life assessment among HIV-positive persons entering the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial
A R Lifson, G A Grandits, E M Gardner, et al.
Page
of 22
Search research articles
Search
Showing results (131-140 of 219) with videos related to
Sort By:
Page
of 22
Chest
|
July 1, 1997
Short-term incarceration for the management of noncompliance with tuberculosis treatment
W J Burman, D L Cohn, C A Rietmeijer, et al.
Plos Medicine
|
August 22, 2008
Ensuring the involvement of children in the evaluation of new tuberculosis treatment regimens
William J Burman, Mark F Cotton, Diana M Gibb, et al.
AIDS Patient Care and Stds
|
August 2, 2014
Engagement-in-care during the first 5 years after HIV diagnosis: data from a cohort of newly HIV-diagnosed individuals in a large US city
Sarah E Rowan, William J Burman, Steven C Johnson, et al.
Neurobiology of Disease
|
May 22, 2025
Network models incorporating chloride dynamics predict optimal strategies for terminating status epilepticus
Christopher B Currin, Richard J Burman, Tommaso Fedele, et al.
Journal of Clinical Microbiology
|
April 1, 1997
The diagnostic yield of acid-fast-bacillus smear-positive sputum specimens
B L Stone, W J Burman, M V Hildred, et al.
The American Journal of Medicine
|
November 23, 2013
Avoidable antibiotic exposure for uncomplicated skin and soft tissue infections in the ambulatory care setting
Hermione J Hurley, Bryan C Knepper, Connie S Price, et al.
Nature Reviews. Neurology
|
May 10, 2022
Why won't it stop? The dynamics of benzodiazepine resistance in status epilepticus
Richard J Burman, Richard E Rosch, Jo M Wilmshurst, et al.
Nature Reviews. Neurology
|
May 18, 2022
Author Correction: Why won't it stop? The dynamics of benzodiazepine resistance in status epilepticus
Richard J Burman, Richard E Rosch, Jo M Wilmshurst, et al.
AIDS Care
|
October 6, 2025
The "ART review": formalizing a process to document complex HIV treatment histories and to support treatment optimization
Kellie L Hawkins, Leila S Hojat, Carrie Hicks, et al.
HIV Medicine
|
February 26, 2015
Quality of life assessment among HIV-positive persons entering the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial
A R Lifson, G A Grandits, E M Gardner, et al.
Page
of 22